These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23234587)

  • 21. Antipsychotic use and the risk of rhabdomyolysis.
    Packard K; Price P; Hanson A
    J Pharm Pract; 2014 Oct; 27(5):501-12. PubMed ID: 24429293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse events in children and adolescents treated with quetiapine: an analysis of adverse drug reaction reports from the Danish Medicines Agency database.
    Jakobsen KD; Wallach-Kildemoes H; Bruhn CH; Hashemi N; Pagsberg AK; Fink-Jensen A; Nielsen J
    Int Clin Psychopharmacol; 2017 Mar; 32(2):103-106. PubMed ID: 27685179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Olanzapine induced rhabdomyolysis and serum creatine kinase increase].
    Ribeyron S; Guy C; Koenig M; Cathébras P
    Rev Med Interne; 2009 Jun; 30(6):477-85. PubMed ID: 19307047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of clozapine use during pregnancy: Analysis of international pharmacovigilance data.
    Beex-Oosterhuis MM; Samb A; Heerdink ER; Souverein PC; Van Gool AR; Meyboom RHB; van Marum RJ
    Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):725-735. PubMed ID: 32378285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antipsychotics and rhabdomyolysis. Differential diagnosis and clinical significance of elevated serum creatine kinase levels in psychiatric practice].
    Vörös V; Osváth P; Fekete S; Tényi T
    Psychiatr Hung; 2009; 24(3):175-84. PubMed ID: 19794225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neuroleptic malignant syndrome after 30 years treatment with clozapine: a rarely seen differential diagnosis on intensive care units].
    Franzen D; Burkhard J; Corti N; Schüpbach D; Fontanel D; Stäubli M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Feb; 41(2):125-7. PubMed ID: 16493563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is There a Potential of Misuse for Quetiapine?: Literature Review and Analysis of the European Medicines Agency/European Medicines Agency Adverse Drug Reactions' Database.
    Chiappini S; Schifano F
    J Clin Psychopharmacol; 2018 Feb; 38(1):72-79. PubMed ID: 29210868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rhabdomyolysis and acute renal failure during high-dose haloperidol therapy.
    Marsh SJ; Dolson GM
    Ren Fail; 1995 Jul; 17(4):475-8. PubMed ID: 7569118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of Hepatobiliary Disorder Reports Associated With the Use of Herbal Medicines in the Global Suspected ADR Database Vigibase.
    van Hunsel F; van de Koppel S; Skalli S; Kuemmerle A; Teng L; Wang JB; Barnes J
    Front Pharmacol; 2019; 10():1326. PubMed ID: 31780942
    [No Abstract]   [Full Text] [Related]  

  • 31. Suspected adverse reactions reported for blood, blood components, and blood products in VigiBase.
    Samukange WT; Lu TA; Souverein PC; Gardarsdottir H; Mantel-Teeuwisse AK
    Transfusion; 2023 May; 63(5):982-992. PubMed ID: 36994873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.
    Potkin SG; Raoufinia A; Mallikaarjun S; Bricmont P; Peters-Strickland T; Kasper W; Baker RA; Eramo A; Sanchez R; McQuade R
    Curr Med Res Opin; 2013 Oct; 29(10):1241-51. PubMed ID: 23822566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neuroleptic malignant syndrome with rhabdomyolysis and muscle rupture].
    Nikić S; Jović-Stosić J; Vucinić S; Todorović V; Babić G; Srnić D; Djordjević D; Stojanović V; Spasić V
    Vojnosanit Pregl; 2001; 58(2):199-203. PubMed ID: 11475676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reporting patterns indicative of adverse drug interactions: a systematic evaluation in VigiBase.
    Strandell J; Caster O; Bate A; Norén N; Edwards IR
    Drug Saf; 2011 Mar; 34(3):253-66. PubMed ID: 21332249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease-related adverse events following non-live vaccines: investigation of a newly described reporting bias through the analysis of the WHO Global ICSR Database, VigiBase.
    Roberto G; Zanoni G
    Vaccine; 2014 May; 32(26):3328-35. PubMed ID: 24291198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suspected cutaneous adverse drug reactions reported with traditional medicines: analysis of data for United Nations Asia region from WHO VigiBase.
    Barvaliya MJ; Chetan AC; Chandan N; Ray SK; Hegde HV; Unger BS; Patel TK; Roy S
    Front Pharmacol; 2023; 14():1088841. PubMed ID: 37324461
    [No Abstract]   [Full Text] [Related]  

  • 38. Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre.
    Star K; Sandberg L; Bergvall T; Choonara I; Caduff-Janosa P; Edwards IR
    Pharmacoepidemiol Drug Saf; 2019 May; 28(5):680-689. PubMed ID: 30767342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clozapine and myocarditis: a case series from the New Zealand Intensive Medicines Monitoring Programme.
    Hill GR; Harrison-Woolrych M
    N Z Med J; 2008 Oct; 121(1283):68-75. PubMed ID: 18841187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.